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Background: Herpes simplex virus type-1 (HSV-1) can cause chronic ulcerative infection in immuno- 
suppressed children leading to latency with subsequent reactivate in the conjunctiva resulting in 
scarring, thickening of the cornea and blindness. They are also common cause of fatal sporadic 
encephalitis in 70% of paediatric patients. This cross sectional study determined the prevalence of HSV-
1 in children in Kaduna State, Nigeria.
Method: A total of 377 blood samples were collected from children less than five years old attending 
some selected hospitals in Kaduna State and analyzed for HSV-1 IgG antibodies employing Enzyme 
immune assay technique by using commercially available ELISA Kits. 
Results: Sero-prevalence rate of 57.8 % (218 /377) was obtained. The highest prevalence of HSV-1 
infection was obtained in children in age group 49-60 months (85.2%) and lowest in children in age 
group 13-24 months (44.8%). Further analysis of the result of children less than one year old showed that 
children 9-16 weeks old were more susceptible to HSV-1 infection. HSV-1 infection was significantly 
2 associated with age (χ =37.92, df = 4, p = 0.001).  Though a higher prevalence was obtained in female 
children (61.5%) than male children (54.5%), the difference observed in the prevalence was not 
2statistically significant (χ =1.84, df =1, P =0.105).HSV-1 infection was significantly associated with 
2children who were in school (χ = 15.28, df = 1, P= 0.001) with a higher prevalence of 74.3%.
Conclusion: Over half of the children sampled were protected from HSV-1 infection while 42.2% were 
susceptible to the infection and were at risk of developing severe HSV-1 manifestation which includes 
keratitis, encephalitis and Keratoconjunctivitis. 
Keywords: Seroprevalence, Herpes Simplex Virus Type-1, Children, ELIZA, Kaduna State, Nigeria
ABSTRACT
INTRODUCTION morbidity and mortality (3, 8).
Prevalence of HSV infection varies 
throughout the world, poor hygiene, overcrowding, 
low socio-economic status, birth in developing 
country have been identified as some of the risk factors 
associated with the virus (2, 9).Herpes Simplex Virus 
type-1 is acquired through direct contact with infected 
lesions and body fluids. The prevalence of HSV-1 
infection increases progressively from childhood to 
adulthood, the seroprevalence being inversely 
proportional to socioeconomic background ( ).The 
virus may reactivate in the conjunctiva and 
reoccurrences of HSV-1 results in scarring, thickening 
of the cornea and blindness (3, 10). In the United 
States, HSV-1 infections are second only to trauma as 
cause of corneal blindness (3). There is however no 










erpes Simplex Virus (HSV) belongs to the 
family Herpesviridae and is a large enveloped HDNA virus of icosahedral symmetry divided 
into two types, HSV1 and HSV 2 (1-3). The virus is an 
ever-present pathogen that usually causes either 
asymptomatic infection or skin and mucosal diseases 
(4). Herpes Simplex Virus type-1 (HSV-1) is the most 
common cause of sporadic fetal encephalitis in 
paediatric children (3,5,6) and accounts for 23% of 
serious neurological disease in children (7). Neonatal 
herpes is a potentially devastating consequence of 
perinatal transmission of HSV, with significant 
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blindness and HSV-1 in Nigeria where we have many 
blind individuals.
Herpes Simplex Viruses have become a world 
health problem because of its devastating clinical 
manifestations amongst HIV/AIDS children (2, 9).The 
virus is not a reportable disease in Nigeria and there is a 
dearth of information on its seroprevalence in 
neonates and children. The study was therefore 
conducted to determine the seroprevalence of HSV-1 
infection in children 0-5 years attending some selected 
hospitals in Kaduna state, Nigeria.
Analysis of Sera by Enzyme-Linked Immunosorbent 
Assay 
The sera were tested for the presence of HVS-1 IgG 
antibodies using a commercially available IgG 
enzyme-linked Immunosorbent assay (ELISA) Kit 
manufactured by DIAGNOSTIC AUTOMATION, INC. 
USA. The ELISA uses HSV-1 antigens for the detection 
of anti-HSV-1 IgG antibodies in serum. The 
absorbance was read at 450 nm using an ELISA micro 
titer plate reader (Sigma Diagnostic). The presence or 
absence of anti-HSV-1-specific IgG antibodies in the 
test samples was calculated according to the 
manufacturer's instructions. Results were obtained by 
comparing the antibody titers with the cut off values 
of the positive and negative controls.
Statistical Analysis
Data obtained were analyzed using SPSS statistical 
package version 17. Pearson Chi-square test of 
association was used to determine association between 
variables and seropositivity to HSV-1 infection in the 
children at 0.05 significant levels.
Materials and Methods
Study Area
The study was conducted in Kaduna State, Nigeria. 
Kaduna state occupies part of the north central region 
of Nigeria. The Global location of Kaduna state is 
0 0between 06  and 113  north of the equator and 
occupies an area of approximately 48,732.2 square 
kilometers.
Study Population
A total of 377 blood samples were randomly collected 
from male and female children 0-5 years old in three 
selected health care facilities from January 2011 to 
August 2011.The health care facilities include Barau 
Dikko Specialist Hospital (BDSH) Kaduna, Ahmadu 
Bello University Teaching Hospital (ABUTH) Zaria and 
Institute for Child Health (ICH) Banzazzau, Zaria.
Ethical Approval 
Approval for the study was obtained from the ethical 
committee of the hospitals and consent for the 
participation of the children in the study were 
obtained from parents or care givers. Prior to the 
sample collection, demographic and clinical 
information of the children were obtained using 
structured questionnaires administered to parents or 
care givers who consented to the study.
Sample Collection and Processing
Using a sterile disposable syringe, 3ml of venous blood 
was collected aseptically by a clinician and dispensed 
into a plain sterile sample bottles and transported 
safely to the laboratory. The blood samples were 
centrifuged at 2,500 rpm and serum collected into 
clean, sterile dry plain sample bottles using a clean dry 
0Pasteur pipette. The sera were stored at -20 C until 
needed for analysis (11).
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Of the 377 serum samples obtained from children aged 
0-5 years, 218 were seropositive to HSV-1, giving a 
prevalence of 57.8% (Table 1). Analysis of the results 
by gender showed seroprevalence of 54.5% (108/198) 
and 61.5% (110/179) to HSV-1 for male and female 
children respectively (Figure1).Although, the 
prevalence was higher among girls compared to boys, 
the difference was not statistically significant 
2(χ =1.84, df=1, P =0.105).The prevalence of HSV-1 
according to age group is shown in Figure 2. The 
highest prevalence (85.2%: 46/54) was recorded 
among children in age group 49-60 months while the 
lowest (44.8%: 47/105) was recorded in age group 13-
24 months. 
There was a statistically significant association 
2between HSV-1 and age (χ =37.92, df-4, P 
=0.001).Further analysis of the result of children in 
the age group 0-12 months showed a significant 
2association between HSV-1 and age (χ = 20.808, df = 
5, P =0.001). The highest prevalence was recorded in 
children within 9-16 weeks of age (84.6%), followed 
RESULTS 
by children within 0-8 weeks (64.3%), 17-24 weeks 
(62.5%), 25-32 weeks (52.6%), 33-40 weeks (26.3%) 
and the lowest prevalence was observed in children 
within 41-48weeks (23.5%).
2The seroprevalence rate was significantly (χ = 
15.28, df=1, P= 0.001) higher among children in 
school (74.3%: 75/101) compared to children who 
were not in school (51.8%: 143/276) as shown in 
Table 2. Children who were in school were more 
likely to be infected with HSV-1 infection than those 
who were not in school (OR=1.43, 95% CI = 0.5851 
– 0.7898).
The results obtained were analyzed according to the 
mode of delivery of the children enrolled in the study 
(Table 3). There was a higher preponderance in 
children delivered by spontaneous vaginal delivery 
(58.7%: 205/349) as compared to those delivered by 
caesarian section (46.4%; 13/28) though the 
2difference was not statistically significant (χ =1.61, 
df=1, p= 0.142).
The prevalence of HSV-1 infection was 54.1% 
(109/196) in children with 1-3 siblings while 
children with more than 9 siblings had the highest 
prevalence (76.9%:10/13) (Figure 3).The association 
between number of children per family to the 
infection was however not statistically significant 
2(χ =6.45,df=3, p =0.092) 
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Figure 1; Percentage distribution of IgG antibody to HSV-1 in relation 
to gender in children 0-5 years in Kaduna state, Nigeria.
61.50%
54.50%
Figure 2: Percentage distribution of IgG antibody to HSV-1 among different 
age groups in children (0-5) years in children in Kaduna State, Nigeria.
Figure 3: Percentage distribution IgG antibody toHSV-1 in children 0-5 years 
old in relation to number of children per family in children in 
Kaduna State, Nigeria.







BDSH 126 62 49.2 40.63-57.83 
ABUTH 125 80 64.0 55.28-71.88 
ICH 126 76 60.3 61.59-68.47 
TOTAL 377 218 57.8 52.79-62.71 
 
43
Nigerian Journal of Medicine, Vol. 23  No.1,   January-March, 2014,  ISSN 1115-2613







In school 101 75 74.3 64.95-81.78 
Not in school 276 143 51.8 45.93-57.64 
Total 377 218 57.8 52.79-62.71 
 








Normal delivery 349 205 58.7 53.5-63.78 
Caesarian section 28 13 46.4 29.53-64.19 
Total 377 218 57.8 52.79-62.71 
 
A seroprevalence of 57.8% was obtained in this study 
which was relatively high and this could in part be 
attributed to the mode of transmission of HSV-1 
which includes direct contact with lesions and 
through saliva. The result implies that 42.2% of the 
children in the study were susceptible to HSV-1 
infection and were not immunized against the virus. 
These pockets of susceptible children are at risk of 
developing severe HSV-1 manifestation which 
includes gingivitis, Keratoconjunctivitis and fetal 
e n c e p h a l i t i s .  I f  t h e s e  c h i l d r e n  a r e  
immunocompromised and their cellular immunity is 
impaired, infection may spread and involve 
respiratory tract, esophagus and intestinal mucosa as 
has been shown in children with AIDS and patients 
under immunosuppressive treatment like bone 
marrow, renal and cardiac transplant recipients; In 
addition, if any of these susceptible children is 
malnourished, he or she will be prone to fatal 
disseminated HSV infection (3, 5).
The result is similar to the prevalence of 59% obtained 
in children in Eritrea (12), 59% in New Mexico (13) and 
55% in Syria (14)but higher than those reported in 
Germany, Israel and England where a prevalence of 
31%, 38%and 20%were obtained respectively (15-
17).The prevalence rate in this study was however; 
lower than that of 99.7% obtained among older 
DISCUSSION
children in Kaduna state (18) and 69% among adults 
in Plateau state (19). The lower prevalence obtained in 
this study may be as a result of age difference in the 
study population. Earlier studies have found the 
prevalence of HSV-1 to increase with age 
progressively (9, 20-22). The published studies in 
Nigeria sampled older children and adults while the 
present study sampled younger children 0-5 years 
old.
Seropositivity of HSV-1 IgG antibody in relation to 
the selected hospitals showed the lowest and highest 
prevalence amongst children attending BDSH and 
ABUTH respectively. The low prevalence seen in BDSH 
could be due to a number of factors. It could be due to 
higher number of neonates and younger children who 
may not have had contact with the virus seen in the 
unit; or due to increased personal hygiene among the 
patients as the clinic is situated in Kaduna which is an 
urban centre; in addition the clinic is a primary health 
care centre. The higher prevalence recorded for 
ABUTH may be due to increased number of patients 
attending the tertiary health care centre where 
patients with clinical disease are more likely to be 
referred.
Seroprevalence of HSV-1 in this study was higher in 
girls than boys. The higher prevalence observed 
among girls in this study may be due to chance since 
the difference observed was not significant. The 
higher prevalence obtained in females from the study 
agrees with the findings in Europe and USA where 
female children were more likely to be HSV-1 
seropositive than males (20, 23, 24). 
There was a highly statistically significant association 
between age group and infection with HSV-1. The rise 
in seroprevalence rate with age is similar to the 
findings in Tanzania, Germany and Israel where HSV-
1 seroprevalence was found to increase with 
increasing age 16,17, ).The prevalence obtained for 
children in age group 0-12 months and 13-24 
months were similar. The prevalence of 44.8% in age 
group 0-12 months in this study is similar to the 
prevalence (49%) obtained in newborns in England 
and Wales (20). However, prevalence obtained in this 
age group could reflect in part maternal antibody 
(IgG) status, since the antibodies can cross the 
placenta. The decrease in prevalence (44.8%) in age 
group 13-24months could be due to waning of 
maternal antibody. Studies have also revealed that 
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early childhood stress can also elevate antibody levels 
in these children (25). The highest prevalence of the 
infection in age group 49-60 months could be 
associated with increased level of interaction among 
children.
A high prevalence rate of 74.3% was obtained in 
children who were in school in this study compared to 
children who were not in school. Earlier studies have 
not made such comparison. The increased prevalence 
in children who attended formal education may be 
associated with the higher degree of interaction 
amongst children with their peer from variable 
cultures.
There was no statistically significant association 
between the mode of delivery of children and 
seropositivity to HSV-1 infection, although a higher 
prevalence was observed in children delivered via 
normal delivery (spontaneous vaginal delivery) than 
in children delivered via caesarian section. The higher 
prevalence seen in children born via normal delivery 
may be as a result of contact with infected secretion 
from the mucosa lining of female genital tract during 
labour. Caesarian section on the other hand has been 
shown to reduce the risk of transmission from mother 
to child during delivery (26, 27).
The high seroprevalence of HSV-1 among children 
with high number of siblings seen in this study could 
be associated to the closer interaction amongst the 
siblings and overcrowding as also postulated by 
Brinzli et al (28).
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Herpes simplex virus type-1seroprevalence of 
57.8%was obtained in children in this study, 
indicating that over half of the children sampled were 
protected from HSV-1 infection. However, 42.2% of 
the children were susceptible to the infection and were 
at risk of developing keratitis, encephalitis and 
Keratoconjunctivitis. Younger age and school 
attendance were risk factors associated with HSV-
1infection among children in the study.
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